FXEmpire
11 Nov 2026, 16:49 UTC · 29m ago
Sales of Pharmaceuticals, GLP-1s Send McKesson Shares to New Highs
Impact · against what's priced in
McKesson's latest earnings and guidance are already largely baked into the current stock price, which has risen 32% this year to reflect these growth trends. The reported GLP-1 revenue and EPS guidance are consistent with the bullish assumptions the market has already adopted.
- MCK+0.05
Already priced in
- The price assumes
The raised fiscal 2027 adjusted EPS guidance of $44.20 to $45.00
The reported guidance of up to $46.40 is a slight incremental increase over the $44.20–$45.00 range the price already assumes, but it confirms the aggressive growth trajectory the market has already priced in.
What MCK's price assumes · Sep 1
